Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

23-valent pneumococcal capsular polysaccharide vaccine

Known as: 23-valent vaccine, pneumococcal polysaccharide PPV23, PCV 23 
 
National Institutes of Health

Related topics

Related topics

5 relations
Merck and Co., Inc.Polyvalent pneumococcal vaccine

Narrower (2)

Pneumo-23Pneumovax 23

Broader (1)

Pneumococcal vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan
Abstract Older adults, particularly those with chronic obstructive pulmonary disease, are advised to receive 23-valent… Expand
2017
2017
Amélioration de la couverture vaccinale antipneumococcique chez les patients pris en charge pour une maladie systémique grâce à un programme de vaccination mené par les infirmières
Introduction Les patients suivis pour une maladie systemique et traites par immunosuppresseurs sont a risque eleve d’infection… Expand
2016
2016
Vaccine profile of PPV23: Beijing Minhai Biotech 23-valent pneumococcal vaccine
ABSTRACT Introduction: Diseases caused by Streptococcus pneumoniae are a major public health problem worldwide, which can be… Expand
Review
2015
Review
2015
Dosing regimen of the 23-valent pneumococcal vaccination: a systematic review.
BACKGROUND Currently, one lifetime booster of a 23-valent pneumococcal polysaccharide vaccine (PPV23) is recommended for those at… Expand
  • figure 1
  • table 1
  • table 2
2014
2014
Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine
The current study examined the safety and immunogenicity of 23-valent pneumococcal capsular polysaccharide vaccine (Pneumo23… Expand
Review
2012
Review
2012
Use of pneumococcal polysaccharide vaccine in children: what is the evidence?
Purpose of review Pneumococcal glycoconjugate vaccines (PCVs) are now widely used in infant immunization schedules. These… Expand
Review
2012
Review
2012
Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers.
For the influenza pandemic of 2009-2010, countries responded to the direct threat of influenza but may have missed opportunities… Expand
  • figure 1
  • table 1
  • table 2
  • table 2
Highly Cited
2010
Highly Cited
2010
Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old
This study evaluated safety & immunogenicity of ZOSTAVAX® (zoster vaccine: ZV) administered concomitantly versus nonconcomitantly… Expand
2008
2008
Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses
We compared the effect of intramuscular vs. inhaled 23-valent pneumococcal capsular polysaccharide vaccine (23-PPV) on pulmonary… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE